Financial News
Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 1.150 |
| Bid (Size) | 1.150 (1) |
| Ask (Size) | 1.380 (10) |
| Prev. Close | 1.150 |
| Today's Range | 1.150 - 1.150 |
| 52wk Range | 1.150 - 3.447 |
| Shares Outstanding | 5,567,490 |
| Dividend Yield | N/A |
Top News
More News
Earnings Scheduled For February 12, 2025
February 12, 2025
Performance
More News
Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 06, 2025
Aytu BioPharma Disclosure Notification
December 03, 2024
Earnings Scheduled For November 13, 2024
November 13, 2024
Aytu BioPharma's Earnings: A Preview
November 12, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Frequently Asked Questions
Is Aytu BioPharma, Inc. - Common Stock publicly traded?
Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
What is the current price of Aytu BioPharma, Inc. - Common Stock?
The current price of Aytu BioPharma, Inc. - Common Stock is 1.150
When was Aytu BioPharma, Inc. - Common Stock last traded?
The last trade of Aytu BioPharma, Inc. - Common Stock was at 04/02/25 04:00 PM ET
What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
The market capitalization of Aytu BioPharma, Inc. - Common Stock is 6.40M
How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
Aytu BioPharma, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
